Medivinc Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
About Medivinc Healthcare
Medivinc Healthcare Private Limited (MHPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 October 2021 (Three years and three months 22 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arvind Burungale, Bajirao Burungale, Vishwajeet Burungale, and One other member serve as directors at the Company.
Company Details
-
Location
Raigarh, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24290MH2021PTC370148
-
Company No.
370148
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Oct 2021
-
Date of AGM
31 Dec 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medivinc Healthcare?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishwajeet Burungale
|
Director | 25-Oct-2021 | Current |
|
Arvind Burungale
|
Director | 25-Oct-2021 | Current |
|
Bajirao Burungale
|
Director | 25-Oct-2021 | Current |
|
Shreyash Burungale
|
Additional Director | 02-Dec-2021 | Current |
Financial Performance of Medivinc Healthcare.
Enhance accessibility to Medivinc Healthcare's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medivinc Healthcare?
Unlock access to Medivinc Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Nucmed Pharma LlpArvind Burungale and Bajirao Burungale are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medivinc Healthcare?
Medivinc Healthcare has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medivinc Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medivinc Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.